IRCT20210325050769N2
Completed
Phase 2
Evaluation of the efficacy and safety of an innovative flavonoid lotion in patients with hemorrhoid; A Randomized Clinical Trial
Bagheiat-allah University of Medical Sciences0 sites100 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Bagheiat-allah University of Medical Sciences
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with grade 2 or higher hemorrhoids
- •Age range 18\-75
- •Lack of drug allergy to lotion
- •Lack of confounding underlying disease such as diabetes
- •Patient satisfaction
Exclusion Criteria
- •Patient dissatisfaction
- •Higher or lower grades of disease
- •Presence of drug allergy to plant Lotion
- •Existence of confounding underlying disease such as diabetes
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 2
Exogenous surfactant obtained from goat lungs for treating respiratory difficulty due to lack of surfactant in preterm neonatesHealth Condition 1: null- Preterm neonates with Respiratory Distress SyndromeCTRI/2015/07/005968All India Institute of Medical Sciences New Delhi101
Not yet recruiting
Not Applicable
To know if the mouth wash prepared from certain herbal products is effective and safe to treat the gingivitisHealth Condition 1: A488- Other specified bacterial diseasesCTRI/2024/01/061413DR ZADC AMU ALIGARH
Completed
Not Applicable
Evaluation of efficucy and safety of newly developed capsule endoscope and software.Small bowel diseaseJPRN-UMIN000010976Center for Diagnostic and Therapeutic Endoscopy, School of Medicine, Keio University40
Completed
Phase 2
Assessment of the Results of Inovo Sense Smile and Inovo Sense Style Filler Injections to Correction Nasolabial FoldsIRCT20220723055530N1Khosro Medisa Teb Company30
Completed
Not Applicable
Prospective evaluation of efficacy and safety of argon plasma coagulation therapy with submucosal injection prior to ablation in Barrett's esophagusC15.5Lower third of oesophagusDRKS00003369HSK Wiesbaden60